Buy Colchicul-Dispert® dragee 15.6 mg, 20 pcs

Colchicul-Dispert® [Colchicine]

Brand Abbott

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Remedy for the treatment of gout.

ATH: Colchicine

Pharmacodynamics:

The anti-gout effect of colchicine is associated with a decrease in leukocyte migration to the focus of inflammation and inhibition of phagocytosis of uric acid salt microcrystals. It also has an antimitotic effect, inhibits (fully or partially) cell division in the anaphase and metaphase stages, prevents neutrophil degranulation. Reducing the formation of amyloid fibrils, prevents the development of amyloidosis.

Highly effective for relieving acute gout. In the first 12 hours of therapy, the condition significantly improves in more than 75% of patients. 80% can cause adverse reactions from the gastrointestinal tract before clinical improvement or at the same time.

At a daily dose of 1-2 mg when taken daily in 3/4 patients with gout reduces the likelihood of recurrent acute attacks.

Warns acute attacks in patients with familial Mediterranean fever (lowers dopamine-beta-hydroxylase activity).

Increases the life expectancy of patients with primary AL amyloidosis.

It has a positive effect on the skin (softening, reducing dryness) with systemic scleroderma.

Pharmacokinetics:

Colchicine is rapidly and rapidly absorbed from the gastrointestinal tract. The average maximum plasma concentration is 4.2 ng / ml and is reached approximately 70 minutes after administration at a dose of 1 mg. The half-life is 9.3 hours. Colchicine quickly penetrates the tissue, has a high volume of distribution of 473 liters. High concentrations of colchicine are found in the liver, kidneys, spleen, leukocytes and gastrointestinal tract. Colchicine is metabolized in the liver and excreted mainly with bile.

Enterohepatic circulation is detected 4-6 hours after oral administration. The largest part of the injected dose is excreted through the intestines and about 23% through the kidneys.

Indications

Acute gout attacks.
Prevention of acute attacks of gout in combination with uricosuric drugs.
Periodic illness (familial Mediterranean fever).

To avoid complications, use only after consulting a doctor.

Composition

1 coated tablet contains:

Active ingredient: Colchicum autumn seed extract [eq. 500 mcg of colchicine] [in the composition of the extract 57-64% lactose, 28-32% microcrystalline cellulose] 15.6 mg;

Excipients:

Core

Copovidone 5.33 mg

Corn starch 27.5 mg

Lactose monohydrate 41.6-43.9 mg

Magnesium stearate 0.33 mg

Palmitostearic acid 1.34 mg

Talc 7.00 mg

Microcrystalline cellulose 3.6-5.2 mg

Shell

Acacia gum 0.3 mg

Carnauba wax 0,140 mg

Carmellose sodium 0,273 mg

Magnesium oxide 2.6 mg

Macrogol 6000 1,093 mg

Opalux AS 250000

[sucrose - 0,7923 mg

dye

Ponso 4R (E124) - 0.26334 mg,

quinoline dye

yellow (Е104) - 0.09652 mg,

titanium dioxide (E171) 0.07904 mg,

Povidone 0.0133 mg] 1.2445 mg

Povidone - K 25 2.186 mg

Sucrose 86.1515 mg

Talc 11, 975 mg

Titanium dioxide (E171) 3.717 mg

Shellac 0.32 mg

No customer reviews for the moment.

Write your review

Dosage and Administration

In the case of an acute gout attack, first take 2 dragees with sugar coating (1 mg of colchicine), and then 1–3 dragees (0.5–1.5 mg of colchicine) every 1–2 hours until the pain subsides. The total dose of the drug taken per day should not exceed 16 pills (8 mg of colchicine). For the prevention of acute attacks of gout in the first few months of treatment with uricosuric drugs take 1-3 pills with sugar coating (0.5-1.5 mg of colchicine) daily or every other day, usually for 3 months.

Sugar coated dragees are swallowed whole, not chewed and squeezed with a sufficient amount of liquid.

Repeated treatment of an acute attack of gout can be carried out no earlier than after 3 days.

Adverse reactions

Diarrhea, nausea, vomiting and stomach pain may occur. Rare cases of leukopenia (a decrease in the number of white blood cells) have been reported. In some cases, after long-term treatment, myoneuropathy (weakness of muscles and nerve tissues) was observed, less often agranulocytosis, hypoplastic anemia (change in the number of blood corpuscles), skin changes and alopecia (baldness).

Contraindications

Hypersensitivity, pregnancy, lactation, hepatic and / or renal failure, pronounced inhibition of bone marrow hematopoiesis.

Lactose intolerance, lacgas deficiency, sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption. Children's age up to 18 years.

Carefully:

Patients with diabetes (due to the content of sucrose and lactose in the composition of the drug).

Drug interactions

In combination with cyclosporine, especially in patients with impaired kidney function, the likelihood of myopathy increases.

Enhances the effect of depriming and sympathomimetic drugs.

Violates the absorption of cyanocobalamin.

Non-steroidal anti-inflammatory drugs and other drugs that cause myelodepression increase the risk of leukopenia and thrombocytopenia.

Anti-gout activity is reduced by cytostatics (increases the concentration of uric acid) and acidifying preparations of urine, which alkalize, enhance the effect.

Kolhikum-Dispert® can be used in combination with allopurinol and preparations of uricosuric action.

Pregnancy and Lactation

Kolkhikum-Dispert® is contraindicated during pregnancy and lactation.

Special instructions

Treatment should be carried out under careful hematological and clinical control.

With the appearance of pronounced side effects from the gastrointestinal tract, reduce the dose or discontinue the drug.

With a decrease in the number of leukocytes below 3000 / μl and platelets below 100000 / μl, the administration is stopped until the blood picture is normalized.

Impact on the ability to drive trans. Wed and fur .:

Does not affect.